Old Web
English
Sign In
Acemap
>
authorDetail
>
Jasminder Soto
Jasminder Soto
Refractory Peripheral T-cell Lymphoma
Oncology
Duvelisib
Internal medicine
Medicine
2
Papers
4
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Dose Optimization of Duvelisib in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma from the Phase 2 Primo Trial: Selection of Regimen for the Dose-Expansion Phase
2019
Blood
Steven M. Horwitz
Neha Mehta-Shah
Barbara Pro
Eric D. Jacobsen
Carla Casulo
Jonathan E. Brammer
Jeff Haney
Hagop Youssoufian
David T. Weaver
Michael Baglio
Jasminder Soto
Narayana I. Narasimhan
Jasmine Zain
Show All
Source
Cite
Save
Citations (1)
The PRIMO study: A phase 2 study of duvelisib efficacy and safety in patients with relapsed or refractory peripheral t-cell lymphoma (PTCL).
2018
Journal of Clinical Oncology
Steven M. Horwitz
Jasminder Soto
Hagop Youssoufian
Deborah Lloyd
Ngocdiep T. Le
Show All
Source
Cite
Save
Citations (3)
1